We've found
6,570 Prostate Cancer
clinical trials
Prostate Adenocarcinoma Clinical Trial
Neoadjuvant Atezolizumab With or Without Enzalutamide in Localized Prostate Cancer Given Before Radical Prostatectomy
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-based Treatment Combinations in Patients With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Upcoming,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer
Status: Upcoming
Updated: 9/24/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer
Status: Upcoming
Updated: 10/2/2012
Click here to add this to my saved trials
Detectable Prostate Nodules Clinical Trial
A Phase 2 Study of Bicalutamide Plus Finasteride in Men With MRI Detectable Prostate Nodules Undergoing Active Surveillance
Status: Upcoming,
Phase
II
Updated: 5/23/2014
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy
Status: Upcoming,
Phase
II
Updated: 7/27/2015
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Randomized AmnioFix Study During Radical Prostatectomy
Status: Upcoming,
Phase
II
Updated: 1/4/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Effects of Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Radiation on Prostate Cancer
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer
Status: Upcoming,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation Therapy
Status: Upcoming
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
A Study of Apalutamide in Participants With High‑Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
A Study of Apalutamide in Participants With High‑Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
A Study of Apalutamide in Participants With High‑Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)
Status: Upcoming,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
Status: Upcoming,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
Status: Upcoming,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Analyses of Human Samples Collected in Clinical Trials
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Prostate Active Surveillance Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Trial of Modifications to Radical Prostatectomy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
A Study of TAS-120 in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Low Risk Prostate Cancer Clinical Trial
Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
6,570 Prostate Cancer
clinical trials
Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Neoadjuvant Atezolizumab With or Without Enzalutamide in Localized Prostate Cancer Given Before Radical Prostatectomy
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Updated: 12/31/1969
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-based Treatment Combinations in Patients With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Upcoming,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 9/24/2012
Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer
Status: Upcoming
Updated: 9/24/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 10/2/2012
Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer
Status: Upcoming
Updated: 10/2/2012
Click here to add this to my saved trials
Detectable Prostate Nodules Clinical Trial
Updated: 5/23/2014
A Phase 2 Study of Bicalutamide Plus Finasteride in Men With MRI Detectable Prostate Nodules Undergoing Active Surveillance
Status: Upcoming,
Phase
II
Updated: 5/23/2014
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 7/27/2015
Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy
Status: Upcoming,
Phase
II
Updated: 7/27/2015
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 1/4/2016
Randomized AmnioFix Study During Radical Prostatectomy
Status: Upcoming,
Phase
II
Updated: 1/4/2016
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Effects of Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Radiation on Prostate Cancer
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer
Status: Upcoming,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation Therapy
Status: Upcoming
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
A Study of Apalutamide in Participants With High‑Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
A Study of Apalutamide in Participants With High‑Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
A Study of Apalutamide in Participants With High‑Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
Status: Upcoming,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)
Status: Upcoming,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
Status: Upcoming,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Updated: 12/31/1969
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
Status: Upcoming,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Analyses of Human Samples Collected in Clinical Trials
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
Prostate Active Surveillance Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Trial of Modifications to Radical Prostatectomy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 6/19/2014
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 6/19/2014
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 6/19/2014
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 6/19/2014
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 6/19/2014
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
A Study of TAS-120 in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Low Risk Prostate Cancer Clinical Trial
Updated: 12/31/1969
Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Updated: 9/23/2015
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Updated: 9/23/2015
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Updated: 9/23/2015
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Updated: 9/23/2015
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Updated: 9/23/2015
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials